Gene · 2739
Papers2,767
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,767
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cobalt and Titanium Alleviate the Methylglyoxal-Induced Oxidative Stress in Pennisetum divisum Seedlings under Saline Conditions. | Metabolites | 2023 | 37999257 | PubTator, text mining | PubMed |
| New cytotoxic dammarane type saponins from Ziziphus spina-christi. | Sci Rep | 2023 | 37996449 | PubTator, text mining | PubMed |
| AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers. | Explor Target Antitumor Ther | 2023 | 37970208 | PubTator, text mining | PubMed |
| Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer. | Front Oncol | 2023 | 37901333 | PubTator, text mining | PubMed |
| Trace Elements Levels in Major Depressive Disorder-Evaluation of Potential Threats and Possible Therapeutic Approaches. | Int J Mol Sci | 2023 | 37894749 | PubTator, text mining | PubMed |
Smoking index and COPD duration as potential risk factors for development of osteoporosis in patients with non-small cell lung cancer - A retrospective case control study evaluated by CT Hounsfield unit. | Heliyon | 2023 | 37886787 | PubTator, text mining | PubMed |
| PARK7 Catalyzes Stereospecific Detoxification of Methylglyoxal Consistent with Glyoxalase and Not Deglycase Function. | Biochemistry | 2023 | 37884446 | PubTator, text mining | PubMed |
| Methylglyoxal, a highly reactive dicarbonyl compound, as a threat for blood brain barrier integrity. | Fluids Barriers CNS | 2023 | 37875994 | PubTator, text mining | PubMed |
| Discovery adductomics provides a comprehensive portrait of tissue-, age- and sex-specific DNA modifications in rodents and humans. | Nucleic Acids Res | 2023 | 37843128 | PubTator, text mining | PubMed |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells. | Int J Mol Sci | 2023 | 37834316 | PubTator, text mining | PubMed |
| Protective effect of heat-processed Gynostemma pentaphyllum on high fat diet-induced glucose metabolic disorders mice. | Front Pharmacol | 2023 | 37822878 | PubTator, text mining | PubMed |
| MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38/ERK activation. | BMC Cancer | 2023 | 37814205 | PubTator, text mining | PubMed |
| The Antitumor Activity of Piplartine: A Review. | Pharmaceuticals (Basel) | 2023 | 37765054 | PubTator, text mining | PubMed |
| Molecular Link between Glo-1 Expression and Markers of Hyperglycemia and Oxidative Stress in Vascular Complications of Type 2 Diabetes Mellitus. | Antioxidants (Basel) | 2023 | 37759966 | PubTator, text mining | PubMed |
| Epigenetic meets metabolism: novel vulnerabilities to fight cancer. | Cell Commun Signal | 2023 | 37735413 | PubTator, text mining | PubMed |
| Glyoxalase I is a novel target for the prevention of metabolic derangement. | Pharmacol Ther | 2023 | 37722607 | PubTator, text mining | PubMed |
| Lysosome-related organelles promote stress and immune responses in C. elegans. | Commun Biol | 2023 | 37704756 | PubTator, text mining | PubMed |
| Local low-frequency vibration accelerates healing of full-thickness wounds in a hyperglycemic rat model. | J Diabetes Investig | 2023 | 37688317 | PubTator, text mining | PubMed |
| A Citrus and Pomegranate Complex Reduces Methylglyoxal in Healthy Elderly Subjects: Secondary Analysis of a Double-Blind Randomized Cross-Over Clinical Trial. | Int J Mol Sci | 2023 | 37685975 | PubTator, text mining | PubMed |
| Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity. | Front Immunol | 2023 | 37675104 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2739/papers?page=8